CYP2C19*2 genotype influence in acute coronary syndrome patients undergoing serial clopidogrel dose tailoring based on platelet function testing: Analysis from randomized controlled trial NCT02096419

Int J Cardiol. 2015:186:282-5. doi: 10.1016/j.ijcard.2015.03.171. Epub 2015 Mar 17.

¹ University of Zagreb School of Medicine, Department for Cardiovascular Diseases, University Hospital Center Zagreb, Kispaticeva 12, 10000 Zagreb, Croatia. Electronic address: jure.samardzic@gmail.com.
² University of Zagreb School of Medicine, Department for Laboratory Diagnostics, University Hospital Center Zagreb, Kispaticeva 12, 10000 Zagreb, Croatia.
³ University of Zagreb School of Medicine, Department for Cardiovascular Diseases, University Hospital Center Zagreb, Kispaticeva 12, 10000 Zagreb, Croatia.
⁴ University of Zagreb School of Medicine, Department for Cardiac Surgery, University Hospital Center Zagreb, Kispaticeva 12, 10000 Zagreb, Croatia.

No abstract available

Keywords: Acute coronary syndrome; CYP2C19; Clopidogrel; Pharmacogenetics; Platelet function testing; Tailoring therapy.

Publication types